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“A splice donor mutation in NAA10 results in the 
dysregulation of the retinoic acid signalling pathway 
and causes Lenz microphthalmia syndrome.” 
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 Lenz Microphthalmia Syndrome (LMS) 
• First described by Dr. Lenz, 1955. 
• Characterized by unilateral or bilateral 
microphthalmia and/or clinical anophthalmia 
with malformations of the ears, teeth, fingers, 
skeleton, and/or genitourinary system; 
developmental delay and/or mental retardation 
are also present. 
• X-linked pattern, very rare. 
• Two disease loci/ (or two diseases?): MCOPS1 
(Xq27-q28), MCOPS2(Xp11.4-p21.2): BCOR 
c.254C>T, p.Pro85Leu. 
 
 
 
 
Am J Med Genet. 2001 Jan 1;98(1): 92-100.  
VS Ogden 
Syndrome 
Rope AF, et al. Am J 
Hum Genet. 2011 Jul 
15; 89(1): 28-43. 
*Phenotype of Carriers  
LMS:  
• Three heterozygotes (VI-4, V-6, V-10) had cutaneous 
syndactyly between the second and third toes and short 
terminal phalanges. 
• Short stature. 
• Recurrent spontaneous abortions. 
• X chromosome skewing? 
 
Ogden Syndrome: 
• X chromosome skewing. 
Pedigree 
Seven generation with 10 
participants in the family of 
mixed European descent. 
 
Note: “…V-12 may represent a form-fruste of LMS.” 
-Am J Med Genet. 2001 Jan 1; 98(1): 92-100.  
Haplotype Analysis 
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Chromosome X showing marker order 
and intermarker distances (cM) based on 
the Marshfield female genetic map. The 
critical region 
associated with Lenz microphthalmia is 
indicated by a vertical black bar. Arrows 
show the relative position of candidate 
genes mapped to the disease. 
If V-12 is unaffected, Xq27.1-Xq28, 
17.65-cM, DXS1232-DXS8043; 
if V-12 is affected, Xq26-qter, 32-cM. 
 
Clinical Reports 
“Three brothers and a maternal uncle had congenital anophthalmia, 
delayed motor development, hypotonia, and mental retardation. They 
also have abnormal ears, high-arched palate, pectus excavatum, finger 
and toe syndactyly, clinodactyly, fetal pads, scoliosis, and cardiac and 
renal abnormalities.” 
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V-10: Obligate carrier 
Whole Exome Sequencing 
• Whole exome sequencing of three affected individuals 
(VI-9, VI-10, VI-11). Total DNA was obtained from per- 
ipheral blood of the patients and controls using standard 
protocols. 
• HiSeq 2000 (Illumina) platform. 
• Extracted all X chromosomal reads. 
• ANNOVAR: 32/42 SNP/DIP variants in VI-9, 37/42 
SNP/DIP variants in VI-10, and 37/36 SNP/ DIP variants in 
VI-11. 
• Five SNPs and 14 DIPs showed overlap among all three 
affected male individuals.  
• Only one variant fulfilled the criteria to be either in an 
exon or a splice junction, which was in the NAA10 gene. 
• This variant predicts a mutation at the intron 7 GT splice 
donor site (c.471+2T→A, ChrX: 153,196,214) of NAA10. 
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Gene Splicing 
Results, RT-PCR validate the aberrant splicing 
WT WT 
VI-11 is the 
most 
severely 
affected 
No Naa10 WT band was 
present in any affected males. 
Cryptic splice site at 
c.471+27, in-frame 
insertion from intron 7. 
WB 
Results, Naa10 localisation IF assay using 
293T cells 
Control Vs VI-11 
fibroblasts: 
 
Endogenous 
Naa10 cell 
localisation does 
not change 
(within the 
cytoplasm and 
nucleus). 
 
Overexpression: 
 
showed punctate 
staining, 
suggesting  of 
protein 
aggregation 
within the 
cytoplasm. 
Results, effect on cell proliferation,  
on Day 5 of culture 
Results, cell growth deficiency  
Cell Growth 
Competition 
Assay: 
Control Vs VI-11. 
Chromatogram 
analysis on the 
ration of WT 
versus mutant 
cells. 
Results, Naa10 knowdown in NDHF cells using 
shRNA lentivirus system 
PS: four out of five cell lines became apoptotic and proceeded to die 
within a week of transduction. 
Results, conservation of AA sequences 
encoded by exon 8 of Naa10 
Results, effect on TSC2, inhibitor of the 
mTOR, which promotes cell proliferation 
Suggests c.471 +2T→A mutation truncated exon 8 and 
leads to the loss of TSC2 binding and a reduction of 
TSC2 protein levels. 
Co-IP on HEK 293T cells. 
WB 
Retinoic Acid Signaling Pathways 
Affymetrix gene 
expression array 
showed significantly 
reduction of  STRA6 
expression in all three 
affected male patients’ 
fibroblast cells. 
Results, 3H-retinol uptake assay 
In humans, mutations of STRA6 (15q24.1) 
results in Matthew-Wood syndrome, 
characterized by anophthalmia or severe 
microphthalmia, and pulmonary hypoplasia 
or aplasia, etc. 
STRA6 binds the RBP4-retinol complex and 
mediates cellular uptake of vitamin A, which is 
the precursor to retinoic acid, a developmental 
morphogen. The RBP4 disease-associated 
mutations abolish STRA6’s vitamin A uptake 
activity. 
qRT-PCR of STRA6 expression 
